期刊论文

Wong, DTW;Su, WC

英文

Cancers

2072-6694

2020

12

8

2041-

10.3390/cancers12082041

Conceptualization, D.T.W.W., F.L. and W.-C.S.; Methodology, F.L., F.W.; Validation, F.L., F.W., L.L., M.M.S., M.T. and J.H.T.; Formal Analysis, Q.Y. and Z.F.; Resources, W.-L.H. and C.-C.L., W.L.; Data Curation, F.L., Q.Y.; Writing—Original Draft Preparation, M.M.S., F.L.; Writing—Review and Editing, F.L., D.T.W.W., F.W., Y.K., D.C., Z.F.; Visualization, M.M.S., F.L., Q.Y.; Supervision, D.T.W.W., F.L. and W.-C.S.; Project Administration, D.T.W.W.; Funding Acquisition, D.T.W.W., F.L. All authors have read and agreed to the published version of the manuscript. This work is supported by NIH R21 CA239052, UH3 TR000923 and UH2 CA206126, U01 CA233370.

本校为其他机构

Mutations identified in the epidermal growth factor receptor (EGFR) predict sensitivity to EGFR-targeted therapy for non-small cell lung carcinoma (NSCLC). We previously reported that Electric Field-Induced Release and Measurement (EFIRM)-based liquid biopsy could detect EGFR ctDNA with >94% concordance with tissue-based genotyping. A side-by-side comparison of concordance of EFIRM and droplet digital PCR (ddPCR) for the detection of the two front-line actionable EFGR mutations was performed with paired plasma and saliva samples from 13 NSCLC p...